ADA example [Bioanalytics]

posted by mittyri  – Russia, 2019-03-18 23:20 (2214 d 23:00 ago) – Posting: # 20047
Views: 6,731

Hi Helmut,

Thank you so much for the detailed answer!

❝ ❝ Even in analytical methodology (say QC samples): isn't possible to handle that values (as they are) for example for the mean evaluation for some level of QC sample?


❝ Not sure what you mean here.


Sorry for incomplete/incorrect question.
Say ADA, getting cut-off point (IV B FDA)
What would be a best tactics for cut-off point selection?
Say the data of healthy volunteers is {100, BLOQ, BLOQ}


Edit: Guidance linked. [Helmut]

Kind regards,
Mittyri

Complete thread:

UA Flag
Activity
 Admin contact
23,422 posts in 4,927 threads, 1,670 registered users;
25 visitors (0 registered, 25 guests [including 12 identified bots]).
Forum time: 23:20 CEST (Europe/Vienna)

To know the history of science is to recognize the mortality
of any claim to universal truth.    Evelyn Fox Keller

The Bioequivalence and Bioavailability Forum is hosted by
BEBAC Ing. Helmut Schütz
HTML5